Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo

Yoshinori Nimura, Tetsuya Kawata, Katsuhiro Uzawa, Junko Okamura, Cuihua Liu, Masayoshi Saito, Hideaki Shimada, Naohiko Seki, Akira Nakagawara, Hisao Ito, Takenori Ochiai, Hideki Tanzawa

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Ku80 is an important component of DNA double-strand break repair, and Ku80 deficiency leads to extreme sensitivity to ionizing radiation. We studied whether radiation therapy combined with Ku80 silencing by small interfering RNA enhances radiation sensitivity in vitro and in vivo. Seven human cancer cell lines were transfected with Ku80 siRNA included in hemagglutinating virus of Japan envelope vector. H1299 cells were implanted into male BALB/C nu/nu nude mice treated with Ku80 siRNA and irradiation. The survival rate of cell lines transfected with Ku80 siRNA decreased by 10% to 26% with 2-Gy irradiation compared with untransfected cell lines. The gamma-H2AX phosphorylation-positive rates of Ku80 siRNA combined treatment 0.5 h after irradiation in A549 cells and 6 h in H1299 cells were significantly higher (77.6%, p=0.033 and 76.7%, p=0.026, respectively), compared with the groups not treated with siRNA. H1299 xenograft tumors treated with combined therapy decreased in volume and re-grew slowly compared with radiation alone. Our results indicate that combined therapy consisting of Ku80 siRNA and irradiation contributes to inhibition of tumor growth and may be a novel strategy for cancer treatment.

Original languageEnglish
Pages (from-to)1477-1484
Number of pages8
JournalInternational Journal of Oncology
Volume30
Issue number6
Publication statusPublished - 2007 Jun
Externally publishedYes

Fingerprint

Radiation Tolerance
Small Interfering RNA
Cell Line
Neoplasms
Sendai virus
Double-Stranded DNA Breaks
Therapeutics
Ionizing Radiation
In Vitro Techniques
Heterografts
Nude Mice
Radiotherapy
Phosphorylation
Radiation
Growth

Keywords

  • HVJ envelope
  • Ku80
  • Radiation sensitivity
  • Small interfering RNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Nimura, Y., Kawata, T., Uzawa, K., Okamura, J., Liu, C., Saito, M., ... Tanzawa, H. (2007). Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo. International Journal of Oncology, 30(6), 1477-1484.

Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo. / Nimura, Yoshinori; Kawata, Tetsuya; Uzawa, Katsuhiro; Okamura, Junko; Liu, Cuihua; Saito, Masayoshi; Shimada, Hideaki; Seki, Naohiko; Nakagawara, Akira; Ito, Hisao; Ochiai, Takenori; Tanzawa, Hideki.

In: International Journal of Oncology, Vol. 30, No. 6, 06.2007, p. 1477-1484.

Research output: Contribution to journalArticle

Nimura, Y, Kawata, T, Uzawa, K, Okamura, J, Liu, C, Saito, M, Shimada, H, Seki, N, Nakagawara, A, Ito, H, Ochiai, T & Tanzawa, H 2007, 'Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo', International Journal of Oncology, vol. 30, no. 6, pp. 1477-1484.
Nimura Y, Kawata T, Uzawa K, Okamura J, Liu C, Saito M et al. Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo. International Journal of Oncology. 2007 Jun;30(6):1477-1484.
Nimura, Yoshinori ; Kawata, Tetsuya ; Uzawa, Katsuhiro ; Okamura, Junko ; Liu, Cuihua ; Saito, Masayoshi ; Shimada, Hideaki ; Seki, Naohiko ; Nakagawara, Akira ; Ito, Hisao ; Ochiai, Takenori ; Tanzawa, Hideki. / Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo. In: International Journal of Oncology. 2007 ; Vol. 30, No. 6. pp. 1477-1484.
@article{7b5e4bc05c6f4e83865377e25d9368aa,
title = "Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo",
abstract = "Ku80 is an important component of DNA double-strand break repair, and Ku80 deficiency leads to extreme sensitivity to ionizing radiation. We studied whether radiation therapy combined with Ku80 silencing by small interfering RNA enhances radiation sensitivity in vitro and in vivo. Seven human cancer cell lines were transfected with Ku80 siRNA included in hemagglutinating virus of Japan envelope vector. H1299 cells were implanted into male BALB/C nu/nu nude mice treated with Ku80 siRNA and irradiation. The survival rate of cell lines transfected with Ku80 siRNA decreased by 10{\%} to 26{\%} with 2-Gy irradiation compared with untransfected cell lines. The gamma-H2AX phosphorylation-positive rates of Ku80 siRNA combined treatment 0.5 h after irradiation in A549 cells and 6 h in H1299 cells were significantly higher (77.6{\%}, p=0.033 and 76.7{\%}, p=0.026, respectively), compared with the groups not treated with siRNA. H1299 xenograft tumors treated with combined therapy decreased in volume and re-grew slowly compared with radiation alone. Our results indicate that combined therapy consisting of Ku80 siRNA and irradiation contributes to inhibition of tumor growth and may be a novel strategy for cancer treatment.",
keywords = "HVJ envelope, Ku80, Radiation sensitivity, Small interfering RNA",
author = "Yoshinori Nimura and Tetsuya Kawata and Katsuhiro Uzawa and Junko Okamura and Cuihua Liu and Masayoshi Saito and Hideaki Shimada and Naohiko Seki and Akira Nakagawara and Hisao Ito and Takenori Ochiai and Hideki Tanzawa",
year = "2007",
month = "6",
language = "English",
volume = "30",
pages = "1477--1484",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo

AU - Nimura, Yoshinori

AU - Kawata, Tetsuya

AU - Uzawa, Katsuhiro

AU - Okamura, Junko

AU - Liu, Cuihua

AU - Saito, Masayoshi

AU - Shimada, Hideaki

AU - Seki, Naohiko

AU - Nakagawara, Akira

AU - Ito, Hisao

AU - Ochiai, Takenori

AU - Tanzawa, Hideki

PY - 2007/6

Y1 - 2007/6

N2 - Ku80 is an important component of DNA double-strand break repair, and Ku80 deficiency leads to extreme sensitivity to ionizing radiation. We studied whether radiation therapy combined with Ku80 silencing by small interfering RNA enhances radiation sensitivity in vitro and in vivo. Seven human cancer cell lines were transfected with Ku80 siRNA included in hemagglutinating virus of Japan envelope vector. H1299 cells were implanted into male BALB/C nu/nu nude mice treated with Ku80 siRNA and irradiation. The survival rate of cell lines transfected with Ku80 siRNA decreased by 10% to 26% with 2-Gy irradiation compared with untransfected cell lines. The gamma-H2AX phosphorylation-positive rates of Ku80 siRNA combined treatment 0.5 h after irradiation in A549 cells and 6 h in H1299 cells were significantly higher (77.6%, p=0.033 and 76.7%, p=0.026, respectively), compared with the groups not treated with siRNA. H1299 xenograft tumors treated with combined therapy decreased in volume and re-grew slowly compared with radiation alone. Our results indicate that combined therapy consisting of Ku80 siRNA and irradiation contributes to inhibition of tumor growth and may be a novel strategy for cancer treatment.

AB - Ku80 is an important component of DNA double-strand break repair, and Ku80 deficiency leads to extreme sensitivity to ionizing radiation. We studied whether radiation therapy combined with Ku80 silencing by small interfering RNA enhances radiation sensitivity in vitro and in vivo. Seven human cancer cell lines were transfected with Ku80 siRNA included in hemagglutinating virus of Japan envelope vector. H1299 cells were implanted into male BALB/C nu/nu nude mice treated with Ku80 siRNA and irradiation. The survival rate of cell lines transfected with Ku80 siRNA decreased by 10% to 26% with 2-Gy irradiation compared with untransfected cell lines. The gamma-H2AX phosphorylation-positive rates of Ku80 siRNA combined treatment 0.5 h after irradiation in A549 cells and 6 h in H1299 cells were significantly higher (77.6%, p=0.033 and 76.7%, p=0.026, respectively), compared with the groups not treated with siRNA. H1299 xenograft tumors treated with combined therapy decreased in volume and re-grew slowly compared with radiation alone. Our results indicate that combined therapy consisting of Ku80 siRNA and irradiation contributes to inhibition of tumor growth and may be a novel strategy for cancer treatment.

KW - HVJ envelope

KW - Ku80

KW - Radiation sensitivity

KW - Small interfering RNA

UR - http://www.scopus.com/inward/record.url?scp=34447275718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447275718&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 1477

EP - 1484

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -